Free Trial

FibroGen (FGEN) Insider Trading & Ownership

FibroGen logo
$0.40 +0.05 (+13.09%)
(As of 12/20/2024 05:40 PM ET)

FibroGen (NASDAQ:FGEN) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
1.98%
Number Of
Insiders Buying
(Last 12 Months)
2
Amount Of
Insider Buying
(Last 12 Months)
$121,383.91
Number Of
Insiders Selling
(Last 12 Months)
0
Get FGEN Insider Trade Alerts

Want to know when executives and insiders are buying or selling FibroGen stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

FGEN Insider Buying and Selling by Quarter

FibroGen Insider and Congressional Trades History

Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
6/12/2024Deyaa AdibInsiderBuy22,123$1.17$25,883.91  
3/7/2024Thane WettigCEOBuy50,000$1.91$95,500.00  
(Data available from 1/1/2013 forward)

FGEN Insider Trading Activity - Frequently Asked Questions

The list of insiders at FibroGen includes Benjamin Cravatt, Christine Chung, Deyaa Adib, Enrique A Conterno, James A Schoeneck, Jeffrey William Henderson, Juan Graham, Mark Eisner, and Thane Wettig. Learn more on insiders at FGEN.

1.98% of FibroGen stock is owned by insiders. Learn more on FGEN's insider holdings.

The following insiders have purchased FGEN shares in the last 24 months: Deyaa Adib ($25,883.91), and Thane Wettig ($95,500.00).

Insiders have purchased a total of 72,123 FGEN shares in the last 24 months for a total of $121,383.91 bought.

The following insiders have sold FGEN shares in the last 24 months: Benjamin Cravatt ($67,718.48), Christine Chung ($626,078.36), Enrique A Conterno ($1,384,192.18), James A Schoeneck ($128,013.00), Jeffrey William Henderson ($11,260.00), Juan Graham ($187,718.39), Mark Eisner ($588,387.42), and Thane Wettig ($71,561.30).

Insiders have sold a total of 163,373 FibroGen shares in the last 24 months for a total of $3,064,929.13 sold.

FibroGen Key Executives

  • Mr. Thane  WettigMr. Thane Wettig (Age 59)
    CEO & Director
    Compensation: $941.79k
  • Ms. Christine L. Chung (Age 56)
    Senior Vice President of China Operations
    Compensation: $915.36k
  • Dr. Barry A. Berkowitz Ph.D.
    Founder
  • Dr. John J. Hunter Ph.D. (Age 61)
    Chief Scientific Officer
  • David DeLucia
    Vice President of Corporate FP&A and Investor Relations
  • Mr. Michael D. Lowenstein J.D.
    Ph.D., Chief Legal Officer
  • Ms. Tricia Stewart
    Chief People Officer
  • Mr. Kirk A. Christoffersen MBA (Age 55)
    Chief Business Officer
  • Dr. Rahul Rajan Kaushik Ph.D.
    Senior Vice President of Pharmaceutical Development, Technical Operations & Manufacturing
  • Dr. Elizabeth Bearby Pharm.D.
    Senior VP of Regulatory, Biometrics, Scientific Communications & Clinical Project Management


This page (NASDAQ:FGEN) was last updated on 12/21/2024 by MarketBeat.com Staff
From Our Partners